Developer docs
API playgroundTry for free, no card

Search company profiles

International Cannabinoid Research Society (ICRS)

Full company profile

uuid0026pt3

Namestring
International Cannabinoid Research Society (ICRS)
Websiteurl
icrs.co
Company typeenum
Private
Founded yearint
1992
Descriptiontext

The International Cannabinoid Research Society (ICRS) is a non-political, non-profit scientific organization founded in 1992 and headquartered in Winston Salem, United States, dedicated to advancing scientific research across all fields of cannabinoids. Its stated mission centers on convening the global cannabinoid research community through membership, an annual symposium, and peer-reviewed scientific exchange. The organization is listed with a headcount of 51-100, which is unusually large for a niche scientific society and may include affiliated researchers, editorial board members, or administrative staff supporting the society's programming.

No product offerings, proprietary technology platforms, pricing structure, customer segments, distribution channels, or revenue mechanics are disclosed in the available input data. The firm's stated website (icrs.co) does not contain substantive content about the society itself in the scraped material; the website content observed relates to an unrelated topic (Swedish-language online casino comparison), suggesting either a domain change, mis-association, or scraping inaccuracy at the source. There is no disclosed funding history, parent organization, subsidiaries, management team, partnerships, awards, patents, or regulatory actions in the provided dataset. As a result, the business model — typically a mix of membership dues, conference registration fees, sponsorships, and academic grants for organizations of this type — cannot be confirmed from the input.

Short descriptiontext

The International Cannabinoid Research Society (ICRS) is a non-profit scientific organization founded in 1992, headquartered in Winston Salem, United States, dedicated to advancing research across all fields of cannabinoids through its membership and scientific community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWinston Salem, United States
HQ citystring
Winston Salem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabinoid research, scientific publications, academic membership, research conferences, pharmacology studies
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Membership Organizations8600
  • Services-Commercial Physical & Biological Research8731
Product category
Scientific Research Society
Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The ICRS is a non-political organization dedicated to scientific research in all fields of cannabinoids. It functions as a scientific society fostering cannabinoid research and scholarly exchange among researchers. It was founded in 1992 and operates as a non-profit with 51–100 employees based in Winston Salem, United States.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product or service information is available in the source data. The website content describes online casinos without Swedish licensing, which is unrelated to the International Cannabinoid Research Society (ICRS).

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers7 records
TypeDirect peer
Description

A clinician-focused scientific membership organization dedicated to cannabis and cannabinoid therapeutics, overlapping heavily with ICRS on the clinical-research side of cannabinoid science.

TypeBroad incumbent
Description

MAPS is a long-established non-profit scientific organization driving research, education, and policy on a related psychotropic class; its structure (non-profit research society, conferences, publications) is a useful adjacent comparison for ICRS's operating model.

3International Society for Neurochemistry (ISN)
TypeBroad incumbent
Description

ISN is a large international scientific society in neurochemistry, where endocannabinoid system research is a significant sub-theme — making it an adjacent incumbent that shares ICRS's underlying researcher base.

TypeRegional player
Description

CCIC is a Canadian scientific consortium focused on cannabinoid research and education, with a mission and structure comparable to ICRS but with a primarily Canadian footprint.

TypeBroad incumbent
Description

AAPS is a much larger pharmaceutical-sciences membership society; it covers cannabinoid pharmacology as one topic among many and represents the type of broad incumbent ICRS competes with for member attention.

6International Association for Cannabinoid Medicines (IACM)
TypeDirect peer
Description

IACM is an international scientific society focused on cannabinoid medicine and research, with a comparable member-driven, conference- and publication-oriented model serving researchers and clinicians in the same field as ICRS.

TypeEmerging player
Description

ACNA is a membership organization supporting evidence-based cannabinoid practice among nurses; it overlaps with ICRS at the intersection of clinical practice and cannabinoid science but is specialty-narrower.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Cannabinoid Research Society (ICRS)

Scientific Research Societyicrs.co

The International Cannabinoid Research Society (ICRS) is a non-profit scientific organization founded in 1992, headquartered in Winston Salem, United States, dedicated to advancing research across all fields of cannabinoids through its membership and scientific community.

What International Cannabinoid Research Society (ICRS) does

The International Cannabinoid Research Society (ICRS) is a non-political, non-profit scientific organization founded in 1992 and headquartered in Winston Salem, United States, dedicated to advancing scientific research across all fields of cannabinoids. Its stated mission centers on convening the global cannabinoid research community through membership, an annual symposium, and peer-reviewed scientific exchange. The organization is listed with a headcount of 51-100, which is unusually large for a niche scientific society and may include affiliated researchers, editorial board members, or administrative staff supporting the society's programming.

No product offerings, proprietary technology platforms, pricing structure, customer segments, distribution channels, or revenue mechanics are disclosed in the available input data. The firm's stated website (icrs.co) does not contain substantive content about the society itself in the scraped material; the website content observed relates to an unrelated topic (Swedish-language online casino comparison), suggesting either a domain change, mis-association, or scraping inaccuracy at the source. There is no disclosed funding history, parent organization, subsidiaries, management team, partnerships, awards, patents, or regulatory actions in the provided dataset. As a result, the business model — typically a mix of membership dues, conference registration fees, sponsorships, and academic grants for organizations of this type — cannot be confirmed from the input.

International Cannabinoid Research Society (ICRS) firmographics

Firmographics
Name
International Cannabinoid Research Society (ICRS)
Website
https://icrs.co
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
51–100 employees
Short description
The International Cannabinoid Research Society (ICRS) is a non-profit scientific organization founded in 1992, headquartered in Winston Salem, United States, dedicated to advancing research across all fields of cannabinoids through its membership and scientific community.
Ownership category
akta.pro rank

Where International Cannabinoid Research Society (ICRS) is headquartered

Location

Headquarters

HQ city
Winston Salem
HQ country
United States
HQ region
North America

Markets served

International Cannabinoid Research Society (ICRS) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

International Cannabinoid Research Society (ICRS) product offering

Product offering

Core offering

The ICRS is a non-political organization dedicated to scientific research in all fields of cannabinoids. It functions as a scientific society fostering cannabinoid research and scholarly exchange among researchers. It was founded in 1992 and operates as a non-profit with 51–100 employees based in Winston Salem, United States.

Product overview

No product or service information is available in the source data. The website content describes online casinos without Swedish licensing, which is unrelated to the International Cannabinoid Research Society (ICRS).

Differentiator

Problem solved

Functional benefit

Companies that use International Cannabinoid Research Society (ICRS)

Customer profile

Ideal customer profiles1 record

International Cannabinoid Research Society (ICRS) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

International Cannabinoid Research Society (ICRS) partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

International Cannabinoid Research Society (ICRS) competitors and assessment

Company assessment

Direct peers

  • Society of Cannabis Clinicians: A clinician-focused scientific membership organization dedicated to cannabis and cannabinoid therapeutics, overlapping heavily with ICRS on the clinical-research side of cannabinoid science.
  • International Association for Cannabinoid Medicines (IACM): IACM is an international scientific society focused on cannabinoid medicine and research, with a comparable member-driven, conference- and publication-oriented model serving researchers and clinicians in the same field as ICRS.

Broad incumbents

  • Multidisciplinary Association for Psychedelic Studies (MAPS): MAPS is a long-established non-profit scientific organization driving research, education, and policy on a related psychotropic class; its structure (non-profit research society, conferences, publications) is a useful adjacent comparison for ICRS's operating model.
  • International Society for Neurochemistry (ISN): ISN is a large international scientific society in neurochemistry, where endocannabinoid system research is a significant sub-theme — making it an adjacent incumbent that shares ICRS's underlying researcher base.
  • American Association of Pharmaceutical Scientists (AAPS): AAPS is a much larger pharmaceutical-sciences membership society; it covers cannabinoid pharmacology as one topic among many and represents the type of broad incumbent ICRS competes with for member attention.

Regional players

Emerging players

  • American Cannabis Nurses Association (ACNA): ACNA is a membership organization supporting evidence-based cannabinoid practice among nurses; it overlaps with ICRS at the intersection of clinical practice and cannabinoid science but is specialty-narrower.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

International Cannabinoid Research Society (ICRS) social profiles

Digital presence

International Cannabinoid Research Society (ICRS) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Cannabinoid Research Society (ICRS) leadership team

Management profile

Number of profiles

Profiles1 record

International Cannabinoid Research Society (ICRS) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Cannabinoid Research Society (ICRS) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Cannabinoid Research Society (ICRS)

What does International Cannabinoid Research Society (ICRS) do?

The ICRS is a non-political organization dedicated to scientific research in all fields of cannabinoids. It functions as a scientific society fostering cannabinoid research and scholarly exchange among researchers. It was founded in 1992 and operates as a non-profit with 51–100 employees based in Winston Salem, United States.

Is International Cannabinoid Research Society (ICRS) a public or private company?

International Cannabinoid Research Society (ICRS) is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was International Cannabinoid Research Society (ICRS) founded?

International Cannabinoid Research Society (ICRS) was founded in 1992. It employs 51 to 100 people.

Where is International Cannabinoid Research Society (ICRS) based?

International Cannabinoid Research Society (ICRS) is headquartered in Winston Salem, United States, in the North America region.

Who are International Cannabinoid Research Society (ICRS)'s main competitors?

Direct peers on record are Society of Cannabis Clinicians and International Association for Cannabinoid Medicines (IACM). Broad incumbents are Multidisciplinary Association for Psychedelic Studies (MAPS), International Society for Neurochemistry (ISN) and American Association of Pharmaceutical Scientists (AAPS). Canadian Consortium for the Investigation of Cannabinoids (CCIC) is listed as a regional player. American Cannabis Nurses Association (ACNA) is listed as an emerging player.

Does International Cannabinoid Research Society (ICRS) have an API?

No public API is recorded for International Cannabinoid Research Society (ICRS).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsUConn Nursing Researchers Honored at Global SymposiumFaculty and graduate students from the University of Connecticut's Elisabeth DeLuca School of Nursing presented cannabinoid research at the 2026 International Cannabinoid Research Society Annual Symposium in Dijon, France. Dr. Steven G. Kinsey delivered the Mid-Career Award Lecture, and doctoral candidates Matt Reck and Maria Jaakson presented findings on cannabinoid receptor signaling and pain mechanisms, both receiving travel awards.GlobeNewswireArtelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society SymposiumArtelo Biosciences presented preclinical data at the ICRS symposium showing its FABP5 inhibitor ART26.12 alleviated osteoarthritis pain in animal models. The drug's efficacy matched naproxen over four weeks without tolerance, and it raised plasma endocannabinoids. The company plans to advance ART26.12 through clinical development.PR NewswireSciSparc to Support 31st Annual ICRS Symposium on Cannabinoids Special EventSciSparc Ltd. announced it will participate in and support the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids, scheduled to be held in Jerusalem, Israel from June 21-24, 2021. The company will sponsor an event celebrating the 90th birthday of Prof. Raphael Mechoulam, who discovered the "entourage effect" phenomenon in 1998 and is recognized as the father of cannabinoid research. SciSparc's drug development programs include SCI-110 for Tourette syndrome and obstructive sleep apnea, SCI-160 for pain treatment, and SCI-210 for autism spectrum disorder and spectrum epilepticus.PR NewswireArtelo Biosciences Announces Five Year Commitment To Sponsor The Young Investigator Award At The International Cannabinoid Research Society Annual SymposiumArtelo Biosciences announced a five-year commitment to sponsor the Young Investigator Award at the International Cannabinoid Research Society's 28th Annual Symposium held June 30-July 5, 2018 in Leiden, Netherlands. The company stated the sponsorship provides access to cutting-edge endocannabinoid research and mentioned existing research collaborations with previous award winners Dr. Saoirse O'Sullivan from the University of Nottingham and Dr. Martin Kaczocha from Stony Brook University. CEO Greg Gorgas emphasized the sponsorship as a strategic opportunity to identify and engage researchers dedicated to endocannabinoid science.PR NewswireKannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) SymposiumKannalife Sciences presented research findings on its cannabinoid-derived drug candidate KLS-13019 at the 27th Annual International Cannabinoid Research Society Symposium in Montreal. The presentation highlighted the molecule's neuroprotective and anti-inflammatory properties, aiming to address limitations associated with standard cannabidiol treatments. The company continues to conduct research at the Pennsylvania Biotechnology Center for potential therapies targeting neurodegenerative diseases.